VKH
IHE icon

Virtu KCG Holdings’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Virtu KCG Holdings’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$798K Sell
15,432
-1,512
-9% -$76.4K 0.02% 740
2017
Q1 		$853K Buy
16,944
+12,675
+297% +$627K 0.02% 843
2016
Q4 		$201K Sell
4,269
-10,305
-71% -$489K 0.01% 2594
2016
Q3 		$726K Sell
14,574
-2,469
-14% -$125K 0.02% 1000
2016
Q2 		$820K Sell
17,043
-32,115
-65% -$1.53M 0.02% 906
2016
Q1 		$2.25M Buy
+49,158
New +$2.3M 0.06% 239
2015
Q4 		– Sell
-22,440
Closed -$1.11M – 3691
2015
Q3 		$1.11M Buy
22,440
+15,549
+226% +$891K 0.02% 808
2015
Q2 		$402K Buy
6,891
+2,097
+44% +$123K 0.01% 1700
2015
Q1 		$276K Buy
+4,794
New +$262K 0.01% 2005
2014
Q4 		– Sell
-10,533
Closed -$493K – 3957
2014
Q3 		$493K Sell
10,533
-68,280
-87% -$3.08M 0.01% 1712
2014
Q2 		$3.55M Buy
78,813
+65,634
+498% +$2.82M 0.06% 270
2014
Q1 		$557K Sell
13,179
-35,226
-73% -$1.48M 0.01% 1849
2013
Q4 		$1.91M Buy
+48,405
New +$1.82M 0.02% 695

Other funds holding IHE

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PAG
Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RTS
Round Table Services Westfield, New Jersey $508M AUM 16.36% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Virtu KCG Holdings's IHE Position: Q2 2017 in Review

Virtu KCG Holdings reduced its iShares US Pharmaceuticals ETF (IHE) stake by 8.9% in Q2 2017, selling an estimated $76.4K and leaving 15,432 shares worth $798K. The position accounts for 0.02% of the portfolio, ranked #740.

Virtu KCG Holdings first reported a position in IHE in Q4 2013 and has held it in 13 quarters since. The position peaked at $3.55M in Q2 2014. 95 funds tracked by Wall St. Rank hold IHE as of Q2 2017.

  • Virtu KCG Holdings held 15,432 shares of iShares US Pharmaceuticals ETF worth $798K as of Q2 2017.
  • Virtu KCG Holdings sold 1,512 iShares US Pharmaceuticals ETF shares in Q2 2017, an estimated $76.4K.
  • iShares US Pharmaceuticals ETF made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #740 holding.
  • Virtu KCG Holdings first reported a position in iShares US Pharmaceuticals ETF in Q4 2013 and has held it in 13 quarters since.
  • Virtu KCG Holdings's iShares US Pharmaceuticals ETF position peaked at $3.55M in Q2 2014.
  • 95 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.